Overview

A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin

Status:
Recruiting
Trial end date:
2024-12-12
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate if a new study drug, NNC0487-0111, is safe and how it works in the participant's body, when given as injections under the skin
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S